De Novo Classification Process (Evaluation of Automatic Class III Designation)

ICR 202111-0910-009

OMB: 0910-0844

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2021-12-02
Supplementary Document
2021-11-22
ICR Details
0910-0844 202111-0910-009
Received in OIRA 201905-0910-006
HHS/FDA CDRH
De Novo Classification Process (Evaluation of Automatic Class III Designation)
Revision of a currently approved collection   No
Regular 12/02/2021
  Requested Previously Approved
36 Months From Approved 08/31/2022
73 185
12,377 10,730
5 7,283

The ICR describes the information collection involved with the De Novo classification process for medical devices. FDA uses the information in the De Novo request to evaluate whether the medical device may be reclassified from Class III to Class I or II, and if applicable, to determine the general and/or special controls necessary to sufficiently regulate the medical device. Respondents to the information collection are medical device manufacturers.

US Code: 21 USC 513 Name of Law: The FD&C Act; Classification of Devices Intended for Human Use
  
US Code: 21 USC 360c Name of Law: Classification of Devices Intended for Human Use

0910-AH53 Final or interim final rulemaking 86 FR 54826 10/05/2021

Yes

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 73 185 -112 0 0 0
Annual Time Burden (Hours) 12,377 10,730 1,647 0 0 0
Annual Cost Burden (Dollars) 5 7,283 -7,278 0 0 0
No
No
The information collection includes program changes and adjustments. Consistent with estimates found in our analysis of impacts for RIN 0910-AH53, we have increased our estimate of the total number of respondents since last OMB review and approval. Also, the burden we previously attributed to guidance instruction regarding De Novo classification requests and withdrawals, we now attribute to requirements found in agency regulations. However, in our estimated burden per response for a De Novo request, we continue to account for burden that may be associated with completion of the Acceptance Checklist. Finally, we have corrected an inadvertent error found in our proposed rulemaking. Cumulatively, these changes and adjustments result in an overall annual increase of burden by 1,647 hours and decrease of responses by 112.

$5,626,100
No
    Yes
    No
No
No
No
No
Domini Bean 301 796-5733 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/02/2021


© 2024 OMB.report | Privacy Policy